Taking positive cues from Nifty healthcare index, domestic pharma stocks outperformed all other sectoral stocks on Friday, with shares of Cipla leading the pack.
Nifty pharma index was the top mover among all the sectoral indices, rallying 2.5 per cent, while Nifty healthcare rose 2.6 per cent.
Outlook for Indian drug exporters turned positive on prospects of firm exports amid the ongoing geo-political scenario, said analysts.
Investors buying on dips after the recent correction also somewhat supported the stocks on Friday.
Shares of Cipla settled nearly 6 per cent higher from the previous close at Rs 1,045.
Laurus Labs shares rose 4.7 per cent, Sun Pharmaceutical's 3.7 per cent, Torrent Pharma's 1.7 per cent, Dr Reddy's Labs 2.1 per cent, and Aurobindo Pharma 1.9 per cent.
--IANS
ad/vd
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU